These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29176092)

  • 21. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient selection in the Medicare End-Stage Renal Disease Program.
    de Lissovoy G
    Med Care; 1988 Oct; 26(10):959-70. PubMed ID: 3139942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoietin & ESRD payments: a promising policy outcome?
    Roe W
    Nephrol News Issues; 1989 Sep; 3(9):34-5. PubMed ID: 2682270
    [No Abstract]   [Full Text] [Related]  

  • 24. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2017 Nov; 82(210):50738-97. PubMed ID: 29091373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palliative dialysis in end-stage renal disease.
    Trivedi DD
    Am J Hosp Palliat Care; 2011 Dec; 28(8):539-42. PubMed ID: 21398269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field?
    Gardner AV
    Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of Race and Poverty With Mortality Among Nursing Home Residents on Maintenance Dialysis.
    Nee R; Thurlow JS; Norris KC; Yuan C; Watson MA; Agodoa LY; Abbott KC
    J Am Med Dir Assoc; 2019 Jul; 20(7):904-910. PubMed ID: 30929962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the Comprehensive End-Stage Renal Disease Care Model With Medicare Payments and Quality of Care for Beneficiaries With End-Stage Renal Disease.
    Marrufo G; Colligan EM; Negrusa B; Ullman D; Messana J; Shah A; Duvall T; Hirth RA
    JAMA Intern Med; 2020 Jun; 180(6):852-860. PubMed ID: 32227133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should the medicare ESRD program pay for daily dialysis? An ethical analysis.
    Anantharaman P; Moss AH
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The end-stage renal disease program. Experience with a chronic disease capitated health plan.
    Paganini EP
    Infect Dis Clin North Am; 2001 Sep; 15(3):721-9. PubMed ID: 11570138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dialysis Initiation and Mortality Among Older Veterans With Kidney Failure Treated in Medicare vs the Department of Veterans Affairs.
    Kurella Tamura M; Thomas IC; Montez-Rath ME; Kapphahn K; Desai M; Gale RC; Asch SM
    JAMA Intern Med; 2018 May; 178(5):657-664. PubMed ID: 29630695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Income-based disparities in outcomes for patients with chronic kidney disease.
    Garg PP; Diener-West M; Powe NR
    Semin Nephrol; 2001 Jul; 21(4):377-85. PubMed ID: 11455526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The costs of dialysis in the USA.
    Garella S
    Nephrol Dial Transplant; 1997; 12 Suppl 1():10-21. PubMed ID: 9075223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.
    Lacson E; Hakim RM
    Am J Kidney Dis; 2011 Apr; 57(4):547-9. PubMed ID: 21333423
    [No Abstract]   [Full Text] [Related]  

  • 37. Special treatment--the story of Medicare's ESRD entitlement.
    Rettig RA
    N Engl J Med; 2011 Feb; 364(7):596-8. PubMed ID: 21323539
    [No Abstract]   [Full Text] [Related]  

  • 38. Health care policies/economics of the geriatric renal population.
    Eggers PW
    Am J Kidney Dis; 1990 Oct; 16(4):384-91. PubMed ID: 2121023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of reimbursement regulations on patient management.
    Hull AR
    Am J Kidney Dis; 1992 Jul; 20(1 Suppl 1):8-11. PubMed ID: 1626555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Big Data in the Development and Evaluation of US Dialysis Care.
    Erickson KF; Qureshi S; Winkelmayer WC
    Am J Kidney Dis; 2018 Oct; 72(4):560-568. PubMed ID: 29921451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.